Pembrolizumab,Trastuzumab,Zolbetuximab,Nivolumab,Ipilimumab,Tislelizumab
Merck,Roche,astellas,BMS,Beigene,leap therapeutics
[]
$alpmy $bgne $bmy $mrk $nvs asco-gi 2023 zolbetuximab opens up a stomach cancer niche 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities